JACLYN MENTZER: Open Payments
NPI 1487899365 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$778 in 29 payments from 11 companies in 2025. Trend: 2023 $656 · 2024 $2,287 · 2025 $778
Food & beverage: $589Education: $189
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $284 |
| ABBVIE INC. | 3 | $177 |
| Organon LLC | 4 | $64 |
| UCB, Inc. | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| LEO Pharma Inc. | 2 | $36 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $32 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Galderma Laboratories, L.P. | 1 | $18 |
| GENZYME CORPORATION | 1 | $14 |
Products named: TREMFYA, RINVOQ, SKYRIZI, VTAMA, Bimzelx, ADBRY, Rhapsido, Zoryve.
Industry payments across ID — which companies pay providers there.
